CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,208 | -99.9% | 360 | -99.9% | 0.00% | -100.0% |
| Q2 2023 | $3,431,501 | -38.4% | 255,320 | -24.0% | 0.32% | -34.0% |
| Q1 2023 | $5,569,222 | -16.8% | 335,900 | -6.6% | 0.48% | -15.7% |
| Q4 2022 | $6,692,280 | +8.3% | 359,800 | -25.3% | 0.57% | +1.3% |
| Q3 2022 | $6,180,000 | +34.5% | 481,700 | -26.5% | 0.56% | +51.9% |
| Q2 2022 | $4,595,000 | -14.7% | 655,600 | +0.9% | 0.37% | +5.7% |
| Q1 2022 | $5,388,000 | +8063.6% | 649,900 | +3722.9% | 0.35% | +3063.6% |
| Q4 2017 | $66,000 | – | 17,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |